Skip to search formSkip to main contentSkip to account menu

New Approaches to Brain Tumor Therapy Consortium

Known as: NABTT 
The primary objective of the "New Approaches to Brain Tumor Therapy (NABTT)" CNS Consortium is to improve the therapeutic outcome for adults with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
2014 Background: Recent findings suggest that Ca2+-permeable AMPA receptors play a crucial role in the proliferation and mobility… 
2008
2008
Elevated factor VIII activity is common in patients with newly diagnosed high-grade gliomas
2035 Background: Patients with malignant gliomas are at high risk for venous thromboembolism (VTE). The reason for this… 
2008
2008
A phase II trial of radiation plus temozolomide followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma multiforme (NABTT #0501)
2055 Background: Polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose (poly-ICLC), is a double… 
2005
2005
NABTT 2105: A phase I dose-escalation trial of GliaSite brachytherapy with conventional radiation therapy for newly diagnosed glioblastoma multiforme
1570 Background: NABTT opened trial 2105 to determine the maximum tolerated dose (MTD) of GliaSite Brachytherapy (GSBT) with… 
2004
2004
Updated results from NABTT CNS consortium studies in primary CNS lymphoma
1519 Background: Optimal therapy for patients with newly diagnosed PCNSL has not been defined. Methods: From 6/98–12/99, The New… 
1998
1998
"NABTT Consortia, Its Objectives, Organization, and Contributions to Neuro-oncology to Date and Ambitious Plans for Future Progress," by Stuart A. Grossman, MD, of The Johns Hopkins Oncology Center;